U.S. Court Lifts Ban on Competitor to AstraZeneca PLC's Nexium

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A U.S. court has lifted a temporary block stopping South Korea's Hanmi Pharmaceutical from launching a close relative of AstraZeneca's (AZN.L) Nexium stomach-acid drug in the United States. AstraZeneca said on Wednesday that the U.S. Court of Appeals for the Federal Circuit had removed the temporary injunction on Hanmi's esomeprazole strontium product that had been imposed last month while a legal dispute continues.

Help employers find you! Check out all the jobs and post your resume.

Back to news